BiotechTube
Home/Akribion Therapeutics/Dr. Paul Scholz
DP

Dr. Paul Scholz

Head of Research and Development

Akribion Therapeutics

Therapeutic Areas

OncologyAutoimmune DiseasesFibrosisInfectious Diseases

Akribion Therapeutics Pipeline

DrugIndicationPhase
G-dase E for HPV+ OPSCCHPV-induced Oropharyngeal Head & Neck Cancer (OPSCC)Pre-clinical

Leadership Team at Akribion Therapeutics

MK
Michael Krohn
Co-Founder & Co-CEO
LL
Lukas Linnig
Co-Founder & Co-CEO
View full Akribion Therapeutics profile